Skip to content
Screener

D&A at other companies

Abbott logo
AbbottABT
$402M+12.6%
Haemonetics logo
HaemoneticsHAE
$27.11M-5.7%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$60K+22.4%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$5.11M+67.9%
Medtronic logo
MedtronicMDT
$716M-14.8%
ITG
Integer HoldingsITGR
$35.01M+17.4%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Deferred income tax (benefit) expense(89,945)2,763
Remeasurement of derivative instruments52,213(27,260)
Share-based compensation25,15216,957
Depreciation17,05213,293
Gain on sale of investment(13,648)
Amortization of intangible assets11,2268,656
Remeasurement of contingent consideration to fair value10,5043,709
Amortization of debt issuance costs9,70711,397

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's D&A?
LivaNova (LIVN) reported D&A of $8.75M in Q2 2026.
How has LivaNova's D&A changed year-over-year?
LivaNova's D&A increased by 27.3% year-over-year, from $6.87M to $8.75M.
What is the long-term trend for LivaNova's D&A?
Over 4 years (2021 to 2025), LivaNova's D&A has grown at a 1.9% compound annual growth rate (CAGR), from $26.52M to $28.56M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Ask your AI about LivaNova's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude